Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.
about
High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titersImmunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.Gamma-Irradiated Influenza A Virus Provides Adjuvant Activity to a Co-Administered Poorly Immunogenic SFV Vaccine in Mice.Viral kinetics of enterovirus 71 in human abdomyosarcoma cellsHIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaquesA large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccineGambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunityProfiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without InfectionA microneedle patch containing measles vaccine is immunogenic in non-human primates.Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.Measles vaccination using a microneedle patchHigh Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.Whole genomic sequence and replication kinetics of a new enterovirus C96 isolated from Guangdong, China with a different cell tropism.Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein.Current progress in pulmonary delivery of measles vaccine.Do Australian immunoglobulin products meet international measles antibody titer standards?Highly individual patterns of virus-immune IgG effector responses in humans.Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules.Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014.Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohortA neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment.Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumoniaDevelopment of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.An evaluation of the cold chain technology in South-East, Nigeria using Immunogenicity study on the measles vaccines.Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection.A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
P2860
Q24290580-98D21D39-29D5-4B6F-AA61-5FD1165EA367Q33692361-C9CA477E-CB0E-4FE9-9ABD-9DAA8B58A1DAQ33729612-93A8D43F-01FE-4AAB-944A-BE23C7ADB619Q34062108-9FA3F300-4F09-4F01-90B7-C485578155FBQ34124652-024B0C54-8A65-468E-B898-37DC9AA9EE3AQ34582862-D001E529-D61E-4A09-995A-DD26A050EC2EQ35051541-8B1D763F-7597-49B2-B50E-6E2784E62789Q35113344-82D0644A-1746-4A05-B2ED-C8B0E8EF35D5Q35232801-59789B79-D44C-4B08-B23D-92BB7DCEA878Q35731350-B673DE5E-6141-4FDD-855F-3FA5F358EEF0Q35999709-78A32D36-C277-49EF-87B3-59E834023197Q36011315-950A649E-8022-46B9-9094-0B40C821D551Q36379247-01B06789-D607-41A8-9727-2667BECD9544Q36606717-8E4E7289-0D63-4304-8358-ECBC79BD41DFQ36746957-8C4AACC9-7364-481D-AC8C-A1AB89C0BBE9Q36871954-DB548672-7290-4FBB-9262-2D248E28FEDBQ36994265-66E87999-969C-4BFF-9D9F-069561337F3AQ36997297-DB421146-C6F9-4FB5-AD9D-8C6B96AAF5F2Q37163702-600F2055-4C7B-49DC-B4EA-1A2D8A4DE994Q37404944-EEFE0898-BE9E-4285-841E-FB42A4812413Q37534710-BE2FAB9B-1D3A-4FDB-9150-431052241C46Q37563593-C384DFC3-E4D7-44C6-B83F-39E4FE7B4635Q38176884-53F8FD78-3131-40AF-A385-3006CC08B7CEQ38212517-DE00EB0D-ECF8-439A-9865-9D5D0D8A7B5DQ38808738-D1DF45F4-5A63-42FA-A730-20290D714502Q38953491-38CA26B9-AE8D-4358-AACF-CD26A3FE7942Q39009658-D01AF6C4-BBFD-4AF7-B4D4-0E0065E1C825Q40421196-32B2C3A0-4714-451B-80E9-30567428FC69Q40517930-58339586-8482-4268-AA70-07D41B70BCA1Q40779986-375F2E68-4412-4C79-86DF-849FA8389A02Q41875572-79D5E82D-1B2A-44C4-B782-CD9717C1C9EAQ42169918-68A321DC-5277-45C9-9959-DDDB29A1217FQ42226296-E130C446-28A5-4FBB-9FCE-833FB3348D90Q42639900-A9F961C4-1964-4E51-9AAF-9DBD73E65026Q43097342-5DD25330-C8D9-4803-87F0-2A89F5EAD576Q46385794-25D8D863-E4E1-4B92-96D7-77BD5BB06E16Q46535654-F13DFB38-2CEA-43E3-8FE8-B09D8543DA77Q47111625-D2462667-1262-4D9E-BE0E-39821758AE80Q47141816-544C079D-DB47-48EC-97C0-61BFA9634B13Q52559076-86BF599D-A4A6-45D7-A290-F748459B72FF
P2860
Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Plaque reduction neutralizatio ...... tudies of aerosol vaccination.
@en
Plaque reduction neutralizatio ...... tudies of aerosol vaccination.
@nl
type
label
Plaque reduction neutralizatio ...... tudies of aerosol vaccination.
@en
Plaque reduction neutralizatio ...... tudies of aerosol vaccination.
@nl
prefLabel
Plaque reduction neutralizatio ...... tudies of aerosol vaccination.
@en
Plaque reduction neutralizatio ...... tudies of aerosol vaccination.
@nl
P2093
P921
P1433
P1476
Plaque reduction neutralizatio ...... tudies of aerosol vaccination.
@en
P2093
Bernard J Cohen
Judy Beeler
Nick Andrews
Susette Audet
WHO working group on measles plaque reduction neutralization test
P356
10.1016/J.VACCINE.2007.10.046
P407
P577
2007-11-12T00:00:00Z